Whereas the oncogenicity of NTRK1 fusions was well characterized in papillary thyroid carcinoma [25] and lung adenocarcinoma [21], it remains to be elucidated in colon cancer. The gene discussed is NTRK1; the disease is differentiated thyroid carcinoma.